Steward Partners Investment Advisory, LLC Harrow Health, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 89,220 shares of HROW stock, worth $3.75 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
89,220
Previous 86,625
3.0%
Holding current value
$3.75 Million
Previous $1.81 Million
121.72%
% of portfolio
0.04%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding HROW
# of Institutions
177Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$168 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$91 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$90.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$78.5 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$30.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.14B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...